Home / Expertise / Life Sciences & Healthcare

Life Sciences & Healthcare


We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies, the top ten global medical device companies, the largest biotechnology company and start-ups.

Our life sciences & healthcare teams in Central and Eastern Europe advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very quite often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

Excellent proactive client approach (and the lawyers are) highly engaged and innovative.
Chambers, 2018

With over 300 international specialist lawyers across CMS and the support of the Life Sciences & Healthcare Asia-Pacific Network (LAN), we understand the scientific and commercial aspects, as well as the legal imperatives affecting your life sciences & healthcare business. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics.
With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB EUCOMED, MedTech Europe and EFPIA , we help shape the legal frameworks impacting the life sciences & healthcare sectors.

We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public procurement, pricing and reimbursement, patents, trademarks and other intellectual property, product liability, anti-trust / competition law, commercial and clinical trial agreements as well as regulatory advice and M&A.

The Life Sciences & Healthcare Team in Hungary has strong sector-specific knowledge and first-hand experience of the market, gained through secondments and working as in-house counsel at Life Sciences & Healthcare companies. The team represents the Hungarian subsidiaries of a number of market-leading companies with a continuously growing number of instructions.

Read more Read less
High­lights of our ex­per­i­ence in Lifes­ci­ences in Hun­gary
A sub­si­di­ary of a mul­tina­tion­al phar­ma­ceut­ic­al com­pany on a ma­jor in­vest­ig­a­tion ini­ti­ated by the Hun­gari­an health­care au­thor­ity, the rules con­cern­ing pro­mo­tion of medi­cin­al products, med­ic­al aids and di­et­ary sup­ple­ments; sup­port­ing the cli­ent in the


Show only
01 September 2020
CMS in Hun­gary
CMS in Hun­gary have been ad­vising cli­ents across the re­gion for over 30 years, in both good and bad times. Find out more.
20 April 2020
CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
15 October 2020
Hun­gary is­sues new guid­ance on the pri­vacy as­pects of tak­ing tem­per­at­ure...
On 18 June 2020, the Hun­gari­an gov­ern­ment de­clared a “health crisis situ­ation” with the pas­sage of De­cree No. 283/2020. Ac­cord­ing to this de­cree, Hun­gary’s data pro­tec­tion au­thor­ity (NAIH) is re­vis­ing its f...
1 July 2020
Sign­ing with e-sig­na­ture in CEE
This guide fo­cuses on the most im­port­ant leg­al areas where elec­tron­ic sig­na­tures are usu­ally used: em­ploy­ment law, com­mer­cial con­tracts, real es­tate law, cor­por­ate law and bank­ing and fin­ance con­tracts. This guide ad­di­tion­ally in­cludes help­ful at-a-glance
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
28 September 2020
High Court con­firms that the class of in­ven­tions cre­ated by AI ma­chines...
The High Court has con­firmed that the class of in­ven­tions cre­ated by AI ma­chines is not pat­entable. The de­cision po­ten­tially leaves the door open for hu­man own­ers of AI ma­chines to list them­selves as...
30 October 2019
CMS ad­vises Ad­vent In­ter­na­tion­al and Zentiva on ac­quis­i­tion of Al­vo­gen’s...
CMS ad­vises Ad­vent In­ter­na­tion­al and Zentiva on ac­quis­i­tion of Al­vo­gen’s CEE busi­ness. Find out more.
18 September 2020
Hun­gary ad­opts new AI strategy
The Hun­gari­an gov­ern­ment has ad­op­ted a new com­pre­hens­ive ar­ti­fi­cial in­tel­li­gence (AI) strategy that sets am­bi­tious goals and meas­ures for the de­vel­op­ment and use of AI in Hun­gary through to 2030. The...
30 July 2019
High­lights of our ex­per­i­ence in Lifes­ci­ences in Hun­gary
01 September 2020
Hun­gary re­stores bor­der con­trols on 1 Septem­ber, busi­ness travel im­pacted...
Sim­il­ar to meas­ures in­tro­duced dur­ing the pan­dem­ic’s first wave, the Hun­gari­an gov­ern­ment has ordered the res­tor­a­tion of bor­der con­trols and the clos­ure of bor­ders to non-res­id­ents be­gin­ning 1 Septem­ber 2...
25 April 2018
CMS cor­por­ate com­pli­ance
CMS in Hun­gary has a wealth of ex­per­i­ence in help­ing cli­ents to re­solve their com­pli­ance is­sues. Our team of 12 ex­perts have rep­res­en­ted mul­tina­tion­al cor­por­a­tions and lead­ing loc­al busi­nesses in a wide vari­ety of com­plex com­pli­ance re­views, in­tern­al and
13 August 2020
Sus­tain­able food pro­gress may close glob­al reg­u­lat­ory gap
In­nov­a­tion in the sus­tain­able food sec­tor is for­ging ahead at a re­mark­able pace. Our cur­rent food sources ac­count for nearly one-third of glob­al GHG emis­sions while con­sumers are in­creas­ingly bet­ter edu­cated...